The efficacy of a DNA vaccine containing inserted and replicated regions of the E7 gene for treatment of HPV-16 induced tumors
- 30 April 2007
- Vol. 25 (17) , 3437-3444
- https://doi.org/10.1016/j.vaccine.2006.12.045
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- An improved rearranged Human Papillomavirus Type 16 E7 DNA vaccine candidate (HPV-16 E7SH) induces an E7 wildtype-specific T cell responsePublished by Elsevier ,2006
- Modification of HPV 16 E7 genes: correlation between the level of protein expression and CTL response after immunization of C57BL/6 miceVaccine, 2005
- Cervical Cancer Vaccines: Recent Advances in HPV ResearchViral Immunology, 2003
- Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical CancerNew England Journal of Medicine, 2003
- Improving DNA Vaccine Potency by Linking Marek's Disease Virus Type 1 VP22 to an AntigenJournal of Virology, 2002
- Biological activities and molecular targets of the human papillomavirus E7 oncoproteinOncogene, 2001
- Targeting Human Papillomavirus Type 16 E7 to the Endosomal/Lysosomal Compartment Enhances the Antitumor Immunity of DNA Vaccines against Murine Human Papillomavirus Type 16 E7-Expressing TumorsHuman Gene Therapy, 1999
- Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cellsEuropean Journal of Immunology, 1993
- The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1ACell, 1988
- Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomesCell, 1986